A citation-based method for searching scientific literature

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli, Jessica Read, Peter Langmuir, Anderson J Ryan, Martin J Schlumberger. J Clin Oncol 2012
Times Cited: 839



Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H Shah, Ana O Hoff, Andrew G Gianoukakis, Naomi Kiyota, Matthew H Taylor, Sung-Bae Kim, Monika K Krzyzanowska, Corina E Dutcus, Begoña de las Heras, Junming Zhu, Steven I Sherman. N Engl J Med 2015
Times Cited: 921




List of shared articles



Times cited

Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Poupak Fallahi, Silvia Martina Ferrari, Maria Rosaria Galdiero, Gilda Varricchi, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Salvatore Benvenga, Alessandro Antonelli. Semin Cancer Biol 2022
20

Risk assessment, diagnosis, and treatment of cancer treatment-related adrenal insufficiency.
Annabelle G Hayes, R Louise Rushworth, David J Torpy. Expert Rev Endocrinol Metab 2022
1

CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI.
Cristina Dalmiglio, Lucia Brilli, Michele Campanile, Cristina Ciuoli, Alessandra Cartocci, Maria Grazia Castagna. Cancers (Basel) 2022
1

Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.
Lucy X Ma, Osvaldo Espin-Garcia, Philippe L Bedard, Tracy Stockley, Rebecca Prince, Ozgur Mete, Monika K Krzyzanowska. Thyroid 2022
0

Molecular Imaging and Theragnostics of Thyroid Cancers.
Luca Giovanella, Desiree' Deandreis, Alexis Vrachimis, Alfredo Campenni, Petra Petranovic Ovcaricek. Cancers (Basel) 2022
0

Stereotactic radiotherapy (SRT) for differentiated thyroid cancer (DTC) oligometastases: an AIRO (Italian association of radiotherapy and clinical oncology) systematic review.
Valentina Lancellotta, Giuseppe Fanetti, Fabio Monari, Monica Mangoni, Renzo Mazzarotto, Luca Tagliaferri, Carlo Gobitti, Elisa Lodi Rizzini, Sara Talomo, Irene Turturici,[...]. Radiol Med 2022
0

Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development.
Na Qu, Zongguang Hui, Zhixin Shen, Chengxia Kan, Ningning Hou, Xiaodong Sun, Fang Han. Front Endocrinol (Lausanne) 2022
0

Targeted therapy and drug resistance in thyroid cancer.
Yujie Zhang, Zhichao Xing, Tianyou Liu, Minghai Tang, Li Mi, Jingqiang Zhu, Wenshuang Wu, Tao Wei. Eur J Med Chem 2022
0

Effects of tyrosine kinase inhibitors on thyroid function and thyroid hormone metabolism.
Alessio Basolo, Antonio Matrone, Rossella Elisei, Ferruccio Santini. Semin Cancer Biol 2022
8

Real-world insights into the efficacy and safety of tyrosine kinase inhibitors against thyroid cancers.
Lingyu Li, Lin Cheng, Ri Sa, Xian Qiu, Libo Chen. Crit Rev Oncol Hematol 2022
1

Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies.
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa. Cancer Treat Rev 2022
0

American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.
David C Shonka, Alan Ho, Ashish V Chintakuntlawar, Jessica L Geiger, Jong C Park, Nagashree Seetharamu, Sina Jasim, Amr H Abdelhamid Ahmed, Keith C Bible, Marcia S Brose,[...]. Head Neck 2022
1

Nutrition in Advanced Thyroid Cancer Patients.
Laura Agate, Elisa Minaldi, Alessio Basolo, Valentina Angeli, Roberta Jaccheri, Ferruccio Santini, Rossella Elisei. Nutrients 2022
0

Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine.
Antonio Matrone, Carla Gambale, Alessandro Prete, Rossella Elisei. Front Endocrinol (Lausanne) 2022
1

Systemic Therapy in Thyroid Cancer.
Amit Kumar Agrawal, Vanita Noronha, Vijay Patil, Nandini Menon, Akhil Kapoor, Anuradha Chougule, Pratik Chandrani, Kumar Prabhash. Indian J Surg Oncol 2022
0

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer.
S Filetti, C Durante, D M Hartl, S Leboulleux, L D Locati, K Newbold, M G Papotti, A Berruti. Ann Oncol 2022
0

The pathogenesis and treatment differences between differentiated thyroid carcinoma and medullary thyroid carcinoma.
Jingyang Su, Yue Fu, Menglei Wang, Jiang Yan, Shengyou Lin. Curr Med Res Opin 2022
0

Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer.
Francesca Ragusa, Silvia Martina Ferrari, Giusy Elia, Sabrina Rosaria Paparo, Eugenia Balestri, Chiara Botrini, Armando Patrizio, Valeria Mazzi, Giovanni Guglielmi, Rudy Foddis,[...]. Int J Mol Sci 2022
0

The Role of the Kinase Inhibitors in Thyroid Cancers.
Francesca Cuomo, Claudio Giani, Gilda Cobellis. Pharmaceutics 2022
0

Proteinuria is a late-onset adverse event in patients treated with cabozantinib.
V Cappagli, D Moriconi, A G Bonadio, D Giannese, Gaetano La Manna, M Francesca Egidi, G Comai, G Vischini, V Bottici, R Elisei,[...]. J Endocrinol Invest 2021
6

New Horizons: Emerging Therapies and Targets in Thyroid Cancer.
Matthew D Ringel. J Clin Endocrinol Metab 2021
5

Kinase gene fusions: roles and therapeutic value in progressive and refractory papillary thyroid cancer.
Mian Liu, Pei Chen, Hui-Yu Hu, Deng-Jie Ou-Yang, Rooh-Afza Khushbu, Hai-Long Tan, Peng Huang, Shi Chang. J Cancer Res Clin Oncol 2021
3

Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA.
C M Della Corte, F Morgillo. ESMO Open 2021
4

Improvement of Overall Survival Using TKIs as Salvage Therapy in Advanced Thyroid Carcinoma: Real-Life Data on a Single Center Experience.
Lucia Brilli, Cristina Dalmiglio, Tania Pilli, Filomena Barbato, Fabio Maino, Marco Capezzone, Alessandra Cartocci, Maria Grazia Castagna. J Clin Med 2021
2

Perspectives on the Treatment of Advanced Thyroid Cancer: Approved Therapies, Resistance Mechanisms, and Future Directions.
Ashleigh Porter, Deborah J Wong. Front Oncol 2021
13

Molecular-Driven Therapy in Advanced Thyroid Cancer.
Kevin C Miller, Ashish V Chintakuntlawar. Curr Treat Options Oncol 2021
1

Thyroid cancer and COVID-19: experience at one single thyroid disease referral center.
Alessandro Prete, Marco Falcone, Valeria Bottici, Carlotta Giani, Giusy Tiseo, Laura Agate, Antonio Matrone, Virginia Cappagli, Laura Valerio, Loredana Lorusso,[...]. Endocrine 2021
6

In silico modeling of PAX8-PPARγ fusion protein in thyroid carcinoma: influence of structural perturbation by fusion on ligand-binding affinity.
Kaori Sakaguchi, Yoshio Okiyama, Shigenori Tanaka. J Comput Aided Mol Des 2021
0

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
Carrie C Lubitz, Peter M Sadow, Gilbert H Daniels, Lori J Wirth. Thyroid 2021
5

Prognostic and Therapeutic Role of Angiogenic Microenvironment in Thyroid Cancer.
Assunta Melaccio, Lucia Ilaria Sgaramella, Alessandro Pasculli, Giovanna Di Meo, Angela Gurrado, Francesco Paolo Prete, Angelo Vacca, Roberto Ria, Mario Testini. Cancers (Basel) 2021
3

Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.
L Lorusso, L Pieruzzi, M Gabriele, M Nisi, D Viola, E Molinaro, V Bottici, R Elisei, L Agate. J Endocrinol Invest 2021
0

Translational Utility of Liquid Biopsies in Thyroid Cancer Management.
Ayanthi A Wijewardene, Marthe Chehade, Matti L Gild, Roderick J Clifton-Bligh, Martyn Bullock. Cancers (Basel) 2021
0

PRKAR1A and Thyroid Tumors.
Georgia Pitsava, Constantine A Stratakis, Fabio R Faucz. Cancers (Basel) 2021
0

Precision therapy for RET-altered cancers with RET inhibitors.
Kyaw Z Thein, Vamsidhar Velcheti, Blaine H M Mooers, Jie Wu, Vivek Subbiah. Trends Cancer 2021
8

Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.
Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett. J Med Chem 2021
1

[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network].
Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, Stéphane Bardet, Abir Al Ghuzlan, Isabelle Borget, Françoise Borson Chazot, Christine Do Cao, Camille Buffet, Slimane Zerdoud,[...]. Bull Cancer 2021
0

Management of VEGFR-Targeted TKI for Thyroid Cancer.
Tomohiro Enokida, Makoto Tahara. Cancers (Basel) 2021
0

Nephrotoxicity in advanced thyroid cancer treated with tyrosine kinase inhibitors: An update.
Alice Nervo, Francesca Retta, Alberto Ragni, Alessandro Piovesan, Alberto Mella, Luigi Biancone, Marco Manganaro, Marco Gallo, Emanuela Arvat. Crit Rev Oncol Hematol 2021
0


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy